AN2 Therapeutics, Inc.
NASDAQ:ANTX
1.22 (USD) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 21.351 | 15.647 | 27.219 | 12.097 | 4.07 | 5.598 |
| Short Term Investments
| 62.267 | 91.648 | 68.84 | 46.458 | 0 | 0 |
| Cash and Short Term Investments
| 83.618 | 107.295 | 96.059 | 58.555 | 4.07 | 5.598 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 2.344 | 3.212 | 2.562 | 1.551 | 0.164 | 0.102 |
| Total Current Assets
| 86.262 | 110.507 | 98.621 | 60.106 | 4.234 | 5.7 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 0 | 0 | 0.053 | 0 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 5.021 | 27.194 | 3.219 | 3.486 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.804 | 1.043 | 0.667 | 1.724 | 0 | 0 |
| Total Non-Current Assets
| 5.825 | 28.237 | 3.939 | 5.21 | 0 | 0 |
| Total Assets
| 92.087 | 138.744 | 102.56 | 65.316 | 4.234 | 5.7 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 3.317 | 2.676 | 2.122 | 1.063 | 0.132 | 0.051 |
| Short Term Debt
| 0 | 0 | 0.106 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 6.921 | 11.367 | 4.958 | 2.332 | 1.327 | 0.108 |
| Total Current Liabilities
| 10.238 | 14.043 | 7.186 | 3.395 | 1.459 | 0.159 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0.728 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0.002 | 109.332 | 23.094 | 0 |
| Total Non-Current Liabilities
| 0 | 0 | 0.002 | 109.332 | 23.094 | 0.728 |
| Total Liabilities
| 10.238 | 14.043 | 7.188 | 112.727 | 24.553 | 0.887 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 102.56 | 109.319 | 23.07 | 10.614 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -205.776 | -154.455 | -89.723 | -47.384 | -20.319 | -5.801 |
| Accumulated Other Comprehensive Income/Loss
| 0.031 | 0.275 | -0.374 | -0.027 | 0 | 0 |
| Other Total Stockholders Equity
| 287.594 | 278.881 | 185.469 | 0 | -23.07 | 0 |
| Total Shareholders Equity
| 81.849 | 124.701 | 95.372 | -47.411 | -20.319 | 4.813 |
| Total Equity
| 81.849 | 124.701 | 95.372 | -47.411 | -20.319 | 4.813 |
| Total Liabilities & Shareholders Equity
| 92.087 | 138.744 | 102.56 | 65.316 | 4.234 | 5.7 |